Last month Neil Sprackling, a CEO with Swiss Re, cited long COVID as a significant factor contributing to that two per cent ...
Neurocognitive dysfunction is common in offspring with a familial high risk for schizophrenia or bipolar disorder. FHR-SZ offspring show more severe, generalized impairment.
The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...
Patients with MCI, regardless of subtype, have a higher risk of developing hypertension, diabetes, and hyperlipidemia than cognitively normal individuals.
The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.
A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk for the disease.
The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback